Acurx Pharmaceuticals Inc... (ACXP)

0.68

-0.03 (-4.16%)

At close: Mar 03, 2025, 3:59 PM

0.67

-1.87%

Pre-market: Mar 04, 2025, 08:11 AM EST

Acurx Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-14.58M	-12.09M	-12.75M	-4.6M	-5.93M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	3.77M	3.3M	6.74M	1.27M	900.43K
Other Working Capital	30.02K	30.35K	-387.84M	-801.17K	1.05M
Other Non-Cash Items	980.75K	3.3M	850.26K	781.7K	900.43K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	30.02K	1.25M	141.28K	-801.17K	1.05M
Operating Cash Flow	-9.8M	-7.54M	-5.01M	-3.35M	-3.99M
Capital Expenditures	5.00	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	66.5K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.22M	13.00	n/a	n/a	n/a
Financial Cash Flow	8.16M	3.7M	14.8M	4.04M	4.46M
Net Cash Flow	-1.64M	-3.85M	9.78M	692.09K	470.17K
Free Cash Flow	-9.8M	-7.54M	-5.01M	-3.35M	-3.99M